Taiwanese Pharmaceuticals & Biotech Most Popular Stocks

Caliway Biopharmaceuticals

Market Cap: NT$291.6b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

PharmaEssentia

Market Cap: NT$191.9b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

Bora Pharmaceuticals

Market Cap: NT$84.2b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Lotus Pharmaceutical

Market Cap: NT$61.0b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Lumosa Therapeutics

Market Cap: NT$49.4b

A clinical-stage pharmaceutical company, develops therapies and solutions for neurological and oncological diseases in Taiwan, Asia, the Americas, and Europe.

Oneness Biotech

Market Cap: NT$31.8b

Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products primarily in Taiwan.

Polaris Group

Market Cap: NT$28.7b

Offers biotechnology, drug testing, and contract development and manufacturing services.

Center Laboratories

Market Cap: NT$27.8b

A pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally.

Pell Bio-Med Technology

Market Cap: NT$23.8b

A biomedical company, engages in the development of cell culture technologies and techniques for therapeutic applications.

Sunmax Biotechnology

Market Cap: NT$22.6b

A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.

TaiMed Biologics

Market Cap: NT$21.1b

A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.

TTY Biopharm

Market Cap: NT$19.3b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.

EirGenix

Market Cap: NT$19.0b

Operates as a contract development and manufacturing company in Taiwan and internationally.

Handa Pharmaceuticals

Market Cap: NT$18.5b

A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States.

Synmosa Biopharma

Market Cap: NT$15.8b

A specialty pharmaceutical company, researches, develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand in Taiwan.

Ever Supreme Bio Technology

Market Cap: NT$15.6b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.

ScinoPharm Taiwan

Market Cap: NT$15.2b

Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, India, the United States and internationally.

YungShin Global Holding

Market Cap: NT$15.1b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.

Alar Pharmaceuticals

Market Cap: NT$14.5b

A drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.

Lin BioScience

Market Cap: NT$13.3b

A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.

Medigen Vaccine Biologics

Market Cap: NT$12.9b

A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.

Foresee Pharmaceuticals

Market Cap: NT$12.9b

Operates as biopharmaceutical company in the United States, China, and Europe.

Tanvex BioPharma

Market Cap: NT$12.5b

A biopharmaceutical company, researches, develops, manufactures, and sells biosimilar products in Taiwan and the United States.

Gongwin Biopharm Holdings

Market Cap: NT$12.4b

A clinical-stage biopharmaceutical company, develops anticancer drugs.

Acepodia

Market Cap: NT$10.4b

Operates as a clinical stage biotechnology company.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.1b

Standard Chemical & Pharmaceutical Co. Ltd.

AP Biosciences

Market Cap: NT$9.8b

A clinical-stage biopharmaceutical company, researches and develops bispecific antibody drugs for unmet medical needs.

Taho Pharmaceuticals

Market Cap: NT$9.7b

A pharmaceutical company, develops products using transdermal and transmucosal systems in Taiwan.

PharmaEngine

Market Cap: NT$9.7b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

HanchorBio

Market Cap: NT$9.3b

Operates as a biotechnology company that develops biologics for cancer patients.

CHO Pharma

Market Cap: NT$8.2b

Engages in research and development of biotechnology in Taiwan.

Adimmune

Market Cap: NT$7.9b

Engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally.

Formosa Laboratories

Market Cap: NT$7.8b

Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

Mycenax Biotech

Market Cap: NT$7.7b

Provides biopharmaceutical services and solutions for drug development and production in Taiwan.

SCI Pharmtech

Market Cap: NT$7.2b

Together with its subsidiary, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals in Italy, the United States, Japan, Germany, Taiwan, Switzerland, China, and internationally.

TCM Biotech International

Market Cap: NT$6.9b

A biotech company, engages in the research and development of drugs for liver diseases.